Altre lingue AcouSort AB

Azioni

ACOU

SE0009189608

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 11/07/2024			Variaz. 5gg	Var. 1 gen.
17,3 ^SEK	+6,13%		+11,61%	+11,25%

22/05	AcouSort AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
02/05	AcouSort AB (publ) presenterà due poster che evidenziano il valore della preparazione acustica dei campioni	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

AcouSort to participate in a pioneering project to release the potential in extracellular vesicles research	05/06
AcouSort - Riding the acoustic wave	28/05
AcouSort selected by EIC for participation in BIO for the third time and also invited to showcase its solutions in ISCT’s Innovation Zone	24/05
AcouSort AB - Interim Report for the period January to March 2024	22/05
AcouSort AB Reports Earnings Results for the First Quarter Ended March 31, 2024	22/05
AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications	02/05
AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	02/05
Communiqué from the annual general meeting of AcouSort AB (publ)	30/04
AcouSort and Gensensor enter collaboration aiming at improving bioreactor culturing	29/04
AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	29/04
AcouWash placed at two potential OEM partners	26/04
AcouSort Initiates Two AcouWash Lease Collaborations with Potential OEM Partners	26/04
Increased interest for AcouTrap EV isolation for nano flow cytometry applications	04/04
AcouSort restructures its North American sales operation	03/04
AcouSort AB Annual report 2023	02/04
AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
Shareholder interview with AcouSort’s CEO Torsten Freltoft and Commercial Director Agnes Michanek	13/03
Year end report for AcouSort AB 1 January - 31 December 2023	28/02
Significant technical progress in the AcouSome project – two novel patent applications filed	31/01
AcouSort extends collaboration with leading cell therapy company into a third project phase	18/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue AcouSort AB

Azioni

ACOU

SE0009189608

Altre lingue

Filtri